Phase I Study to Assess the Absorption, Metabolism, and Excretion of [14C] Labeled SPN-810M

NCT02023606 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

7

Enrollment

INDUSTRY

Sponsor class

Conditions

Impulsive Aggression Comorbid With ADHD

Interventions

DRUG: SPN-810M

Sponsor

Supernus Pharmaceuticals, Inc.